EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2

E S Matyugina, M S Novikov, L I Kozlovskaya, V P Volok, E Y Shustova, A A Ishmukhametov, S N Kochetkov, A L Khandazhinskaya

Acta Naturae · 2021

DOI: 10.32607/actanaturae.11479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Naturae, 2021. Verfasst von E S Matyugina und 7 weiteren Autor:innen. Beteiligte Einrichtung: Engelhardt Institute of Molecular Biology, Moscow, 119991 Russia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pandemic caused by the novel betacoronavirus SARS-CoV-2 has already claimed more than 3.5 million lives. Despite the development and use of anti-COVID-19 vaccines, the disease remains a major public health challenge throughout the world. Large-scale screening of the drugs already approved for the treatment of other viral, bacterial, and parasitic infections, as well as autoimmune, oncological, and other diseases is currently underway as part of their repurposing for development of effective therapeutic agents against SARS-CoV-2. In this work, we present the results of a phenotypic screening of libraries of modified heterocyclic bases and 5-norcarbocyclic nucleoside analogs previously synthesized by us. We identified two leading compounds with apparent potential to inhibit SARS-CoV-2 replication and EC50 values in a range of 2070 M. The structures of these compounds can be further optimized to develop an antiviral drug.

Schlagwörter

Stichwörter der Autor:innen

SARS-CoV-2antiviral drugsnucleoside analogsnucleosides

Autor:innen und Institutionen

  • Engelhardt Institute of Molecular Biology, Moscow, 119991 Russia.
  • Volgograd State Medical University, Volgograd, 400131 Russia.
  • FSBSI "Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences", Moscow, 108819 Russia.
  • Sechenov Moscow State Medical University, Moscow, 119991 Russia.

Zitieren

APA

Matyugina, E. S., Novikov, M. S., Kozlovskaya, L. I., Volok, V. P., Shustova, E. Y., Ishmukhametov, A. A., Kochetkov, S. N., & Khandazhinskaya, A. L. (2021). Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2. Acta Naturae. https://doi.org/10.32607/actanaturae.11479

Vancouver

Matyugina ES, Novikov MS, Kozlovskaya LI, Volok VP, Shustova EY, Ishmukhametov AA, et al. Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2. Acta Naturae. 2021. doi:10.32607/actanaturae.11479

BibTeX
@article{Matyugina2021,
  author = {Matyugina, E S and Novikov, M S and Kozlovskaya, L I and Volok, V P and Shustova, E Y and Ishmukhametov, A A and Kochetkov, S N and Khandazhinskaya, A L},
  title = {Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5’-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2},
  journal = {Acta Naturae},
  year = {2021},
  doi = {10.32607/actanaturae.11479}
}
Kostenlos starten →